Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald J Connor

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Archives of Neurology|May 11, 2005
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary resultsD Larry Sparks, Marwan N Sabbagh, Donald J Connor, et al.
Parkinsonism & Related Disorders|March 23, 2011
Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?Virgilio Gerald H Evidente, Charles H Adler, Marwan N Sabbagh, et al.
Alzheimer Disease and Associated Disorders|December 14, 2004
Case series of clinically probable dementia with Lewy bodies in two Native AmericansMarwan N Sabbagh, Nina B Silverberg, Douglas Walker, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|June 7, 2016
Sex and post-menopause hormone therapy effects on hippocampal volume and verbal memoryB Blair Braden, Kara B Dassel, Heather A Bimonte-Nelson, et al.
Acta Neuropathologica|September 15, 2010
Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairmentCharles H Adler, John N Caviness, Marwan N Sabbagh, et al.
Current Alzheimer Research|June 25, 2005
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate ADD Larry Sparks, Marwan N Sabbagh, Donald J Connor, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2007
Defining mild cognitive impairment in Parkinson's diseaseJohn N Caviness, Erika Driver-Dunckley, Donald J Connor, et al.
Alzheimer Disease and Associated Disorders|October 9, 2009
Correlation of clinical features with argyrophilic grains at autopsyMarwan N Sabbagh, Sonny S Sandhu, Martin R Farlow, et al.
Acta Neuropathologica|December 4, 2009
Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?Sun-Ah Choi, Virgilio Gerald Hilario Evidente, John N Caviness, et al.
Cleveland Clinic Journal of Medicine|June 11, 2008
Hippocampal volume change in the Alzheimer Disease Cholesterol-Lowering Treatment trialD Larry Sparks, Susan K Lemieux, Marc W Haut, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Archives of Neurology|May 11, 2005
Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary resultsD Larry Sparks, Marwan N Sabbagh, Donald J Connor, et al.
Parkinsonism & Related Disorders|March 23, 2011
Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?Virgilio Gerald H Evidente, Charles H Adler, Marwan N Sabbagh, et al.
Alzheimer Disease and Associated Disorders|December 14, 2004
Case series of clinically probable dementia with Lewy bodies in two Native AmericansMarwan N Sabbagh, Nina B Silverberg, Douglas Walker, et al.
Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition|June 7, 2016
Sex and post-menopause hormone therapy effects on hippocampal volume and verbal memoryB Blair Braden, Kara B Dassel, Heather A Bimonte-Nelson, et al.
Acta Neuropathologica|September 15, 2010
Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairmentCharles H Adler, John N Caviness, Marwan N Sabbagh, et al.
Current Alzheimer Research|June 25, 2005
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate ADD Larry Sparks, Marwan N Sabbagh, Donald J Connor, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 7, 2007
Defining mild cognitive impairment in Parkinson's diseaseJohn N Caviness, Erika Driver-Dunckley, Donald J Connor, et al.
Alzheimer Disease and Associated Disorders|October 9, 2009
Correlation of clinical features with argyrophilic grains at autopsyMarwan N Sabbagh, Sonny S Sandhu, Martin R Farlow, et al.
Acta Neuropathologica|December 4, 2009
Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?Sun-Ah Choi, Virgilio Gerald Hilario Evidente, John N Caviness, et al.
Cleveland Clinic Journal of Medicine|June 11, 2008
Hippocampal volume change in the Alzheimer Disease Cholesterol-Lowering Treatment trialD Larry Sparks, Susan K Lemieux, Marc W Haut, et al.
Pageof 4